The system is intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data taken at different angles and planes, including Axial, Cine, Helical (Volumetric), Cardiac, and Gated acquisitions. These images may be obtained either withor without contrast. This device may include signal analysis and display equipment, patient and equipment supports, components and accessories. This device may include data and image processing to produce images in a variety of transaxial and reformatted planes. Further the images can be post processed to produce additional imaging planes or analysis results. The system is indicated for head, whole body, cardiac and vascular X-ray Computed Tomography applications in patients of all ages. The device output is a valuable medical tool for the diagnosis of disease, trauma, or abnormality and for planning, guiding, and monitoring therapy.
Publicado el 14 de julio de 2021 · Inicio del retiro: 30 de junio de 2021
Resumen
FDA registra el retiro Z-2023-2021 de dispositivos médicos de Clase II, publicado el 14 de julio de 2021 e iniciado el 30 de junio de 2021. Empresa responsable: GE Healthcare, LLC; Estado: En curso; Lote: Revolution CT. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
When adding one or more intended scan groups names must contain only letters, numbers (0-9), or a space or the user interface will not update to confirm the intended group(s) has been added to the acquisition.
Qué hacer
FDA Mandated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- GE Healthcare, LLC
- Distribuidor
- US
- Lote
- Revolution CT
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDACentricity PACS Software Version 7.0 SP0.0.4.73 de agosto de 2022
- FDASIGNA Premier magnetic resonance scanner, model 5748519.27 de julio de 2022
- FDAGE Centricity Universal Viewer Zero Footprint. To view, communicate, process, and display Medical images and13 de julio de 2022
- FDABack up batteries in Avance CS2 and Avance CS2 Pro anesthesia devices manufactured on or after April 1, 20196 de julio de 2022
- FDAAccolade pacemaker, Models: a) L300 b) L301 c) L310 d) L311 e) L321 f) L33114 de julio de 2021
- FDAVivorte Trabexus EB 10 cc Bone Void Filler -Fill bone and/or defect in skeletal system Model Number: 130703-1014 de julio de 2021
Preguntas sobre este retiro
¿The system is intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data taken at different angles and planes, including Axial, Cine, Helical (Volumetric), Cardiac, and Gated acquisitions. These images may be obtained either withor without contrast. This device may include signal analysis and display equipment, patient and equipment supports, components and accessories. This device may include data and image processing to produce images in a variety of transaxial and reformatted planes. Further the images can be post processed to produce additional imaging planes or analysis results. The system is indicated for head, whole body, cardiac and vascular X-ray Computed Tomography applications in patients of all ages. The device output is a valuable medical tool for the diagnosis of disease, trauma, or abnormality and for planning, guiding, and monitoring therapy. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2023-2021 el 14 de julio de 2021. Peligro reportado: When adding one or more intended scan groups names must contain only letters, numbers (0-9), or a space or the user interface will not update to confirm the intended group(s) has been added to the acquisition.
¿Qué debo hacer si tengo este producto?
FDA Mandated · Letter